We're advancing human health through breakthrough research in genomics, immunotherapy, and molecular diagnostics. Join us in shaping tomorrow's healthcare.
DNA Sequencing
Cancer Treatment
Early Detection
At BioGen Labs, we believe in the power of genetic research to revolutionize healthcare. Our world-class team of scientists and researchers work tirelessly to unlock the mysteries of the human genome and develop innovative therapies.
Founded in 1998, we've been at the forefront of biotechnology innovation, consistently pushing the boundaries of what's possible in life sciences. Our state-of-the-art facilities and collaborative approach enable us to tackle the most challenging healthcare problems.
Improving lives through innovation
Research across 30+ countries
Excellence in biotechnology
Partnerships with leading institutions
Our multidisciplinary approach spans across cutting-edge fields in biotechnology and life sciences
Advanced genomic analysis and next-generation sequencing technologies to understand genetic variations and develop personalized medicine approaches.
Learn More โRevolutionary treatments that harness the body's immune system to fight cancer and other diseases, with breakthrough CAR-T cell therapies.
Learn More โCutting-edge diagnostic tools for early disease detection, precision biomarkers, and real-time monitoring of treatment responses.
Learn More โAI-powered drug discovery platforms and high-throughput screening methods to identify promising therapeutic compounds faster.
Learn More โPioneering work in CRISPR-Cas9 gene editing technology to correct genetic defects and develop next-generation therapies.
Learn More โStudying the gut microbiome's role in health and disease, developing probiotic therapies and microbiome-based diagnostics.
Learn More โLeveraging cutting-edge technology to accelerate discovery and deliver breakthrough therapies
Our proprietary NGS platform delivers unprecedented accuracy and speed in genomic analysis, enabling researchers to unlock critical insights faster than ever before.
Industry-leading sequencing accuracy
Rapid results for critical diagnostics
Machine learning for variant interpretation
Secure data sharing and collaboration
Our artificial intelligence platform accelerates drug discovery by predicting molecule behavior, optimizing compounds, and identifying promising candidates.
Screen millions of compounds in hours
Forecast efficacy and safety profiles
Reduce R&D costs by up to 60%
World-renowned scientists and industry leaders driving innovation in biotechnology
CEO & Chief Scientific Officer
Pioneer in genomic research with 20+ years of experience in personalized medicine
VP of Research
Expert in immunotherapy and cancer research, published 100+ papers
Chief Technology Officer
AI and machine learning specialist, former Google Health lead
Medical Director
Board-certified oncologist leading clinical trials and drug development
Stay updated with our latest breakthroughs, publications, and industry insights
Our team demonstrates successful gene correction in patients with rare genetic mutations using novel CRISPR delivery systems.
Our CAR-T cell therapy for solid tumors receives breakthrough designation, accelerating path to patient access.
Machine learning algorithms uncover new therapeutic targets for previously undruggable cancer mutations.
Interested in collaboration, career opportunities, or learning more about our research? We'd love to hear from you.
500 Innovation Drive, Cambridge, MA 02142
info@biogenlabs.com
+1 (617) 555-0123